- Home
- FLOW-USD vs SEPN Comparison
FLOW-USD vs SEPN Comparison
Compare FLOW-USD & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOW-USD
- SEPN
- Stock Information
- Founded
- FLOW-USD N/A
- SEPN 2022
- Country
- FLOW-USD
- SEPN United States
- Employees
- FLOW-USD N/A
- SEPN N/A
- Industry
- FLOW-USD
- SEPN
- Sector
- FLOW-USD
- SEPN
- Exchange
- FLOW-USD
- SEPN NYSE
- Market Cap
- FLOW-USD N/A
- SEPN 1.0B
- IPO Year
- FLOW-USD N/A
- SEPN 2024
- Fundamental
- Price
- FLOW-USD $0.75
- SEPN $21.89
- Analyst Decision
- FLOW-USD
- SEPN Strong Buy
- Analyst Count
- FLOW-USD 0
- SEPN 4
- Target Price
- FLOW-USD N/A
- SEPN $43.67
- AVG Volume (30 Days)
- FLOW-USD N/A
- SEPN 491.8K
- Earning Date
- FLOW-USD N/A
- SEPN 02-15-2025
- Dividend Yield
- FLOW-USD N/A
- SEPN N/A
- EPS Growth
- FLOW-USD N/A
- SEPN N/A
- EPS
- FLOW-USD N/A
- SEPN N/A
- Revenue
- FLOW-USD N/A
- SEPN $981,000.00
- Revenue This Year
- FLOW-USD N/A
- SEPN $406.62
- Revenue Next Year
- FLOW-USD N/A
- SEPN N/A
- P/E Ratio
- FLOW-USD N/A
- SEPN N/A
- Revenue Growth
- FLOW-USD N/A
- SEPN N/A
- 52 Week Low
- FLOW-USD N/A
- SEPN $18.62
- 52 Week High
- FLOW-USD N/A
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- FLOW-USD 45.02
- SEPN N/A
- Support Level
- FLOW-USD $0.68
- SEPN N/A
- Resistance Level
- FLOW-USD $0.75
- SEPN N/A
- Average True Range (ATR)
- FLOW-USD 0.06
- SEPN 0.00
- MACD
- FLOW-USD -0.00
- SEPN 0.00
- Stochastic Oscillator
- FLOW-USD 66.44
- SEPN 0.00
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.